IBDEI1DA ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24221,0)
 ;;=710.9^^133^1475^5
 ;;^UTILITY(U,$J,358.3,24221,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24221,1,1,0)
 ;;=1^710.9
 ;;^UTILITY(U,$J,358.3,24221,1,2,0)
 ;;=2^CONNECTIVE TISSUE DISEASE NEC
 ;;^UTILITY(U,$J,358.3,24221,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,24222,0)
 ;;=453.9^^133^1475^21
 ;;^UTILITY(U,$J,358.3,24222,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24222,1,1,0)
 ;;=1^453.9
 ;;^UTILITY(U,$J,358.3,24222,1,2,0)
 ;;=2^VENOUS EMB/THROMBOSIS NEC
 ;;^UTILITY(U,$J,358.3,24222,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,24223,0)
 ;;=441.00^^133^1475^1
 ;;^UTILITY(U,$J,358.3,24223,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24223,1,1,0)
 ;;=1^441.00
 ;;^UTILITY(U,$J,358.3,24223,1,2,0)
 ;;=2^ANEURYSM,AORTIC W/ DISSECTION,SITE UNSPEC
 ;;^UTILITY(U,$J,358.3,24223,2)
 ;;=^35660
 ;;^UTILITY(U,$J,358.3,24224,0)
 ;;=042.^^133^1476^1
 ;;^UTILITY(U,$J,358.3,24224,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24224,1,1,0)
 ;;=1^042.
 ;;^UTILITY(U,$J,358.3,24224,1,2,0)
 ;;=2^AIDS OR HIV INFECTION,SYMPTOMATIC
 ;;^UTILITY(U,$J,358.3,24224,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,24225,0)
 ;;=540.9^^133^1476^2
 ;;^UTILITY(U,$J,358.3,24225,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24225,1,1,0)
 ;;=1^540.9
 ;;^UTILITY(U,$J,358.3,24225,1,2,0)
 ;;=2^APPENDICITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,24225,2)
 ;;=^270195
 ;;^UTILITY(U,$J,358.3,24226,0)
 ;;=682.9^^133^1476^3
 ;;^UTILITY(U,$J,358.3,24226,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24226,1,1,0)
 ;;=1^682.9
 ;;^UTILITY(U,$J,358.3,24226,1,2,0)
 ;;=2^CELLULITIS AND ABSCESS,SITE NOS
 ;;^UTILITY(U,$J,358.3,24226,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,24227,0)
 ;;=576.1^^133^1476^4
 ;;^UTILITY(U,$J,358.3,24227,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24227,1,1,0)
 ;;=1^576.1
 ;;^UTILITY(U,$J,358.3,24227,1,2,0)
 ;;=2^CHOLANGITIS
 ;;^UTILITY(U,$J,358.3,24227,2)
 ;;=^23291
 ;;^UTILITY(U,$J,358.3,24228,0)
 ;;=574.70^^133^1476^5
 ;;^UTILITY(U,$J,358.3,24228,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24228,1,1,0)
 ;;=1^574.70
 ;;^UTILITY(U,$J,358.3,24228,1,2,0)
 ;;=2^CHOLECYSTITIS
 ;;^UTILITY(U,$J,358.3,24228,2)
 ;;=^304314
 ;;^UTILITY(U,$J,358.3,24229,0)
 ;;=571.5^^133^1476^6
 ;;^UTILITY(U,$J,358.3,24229,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24229,1,1,0)
 ;;=1^571.5
 ;;^UTILITY(U,$J,358.3,24229,1,2,0)
 ;;=2^CIRRHOSIS,NON-ALCOHOLIC
 ;;^UTILITY(U,$J,358.3,24229,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,24230,0)
 ;;=323.9^^133^1476^7
 ;;^UTILITY(U,$J,358.3,24230,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24230,1,1,0)
 ;;=1^323.9
 ;;^UTILITY(U,$J,358.3,24230,1,2,0)
 ;;=2^ENCEPHALITIS/MYELITIS
 ;;^UTILITY(U,$J,358.3,24230,2)
 ;;=^334231
 ;;^UTILITY(U,$J,358.3,24231,0)
 ;;=421.9^^133^1476^8
 ;;^UTILITY(U,$J,358.3,24231,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24231,1,1,0)
 ;;=1^421.9
 ;;^UTILITY(U,$J,358.3,24231,1,2,0)
 ;;=2^ENDOCARDITIS,ACUTE,UNSPEC
 ;;^UTILITY(U,$J,358.3,24231,2)
 ;;=^269701
 ;;^UTILITY(U,$J,358.3,24232,0)
 ;;=422.90^^133^1476^10
 ;;^UTILITY(U,$J,358.3,24232,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24232,1,1,0)
 ;;=1^422.90
 ;;^UTILITY(U,$J,358.3,24232,1,2,0)
 ;;=2^MYOCARDITIS,ACUTE,UNSPEC
 ;;^UTILITY(U,$J,358.3,24232,2)
 ;;=^269702
 ;;^UTILITY(U,$J,358.3,24233,0)
 ;;=728.86^^133^1476^11
 ;;^UTILITY(U,$J,358.3,24233,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24233,1,1,0)
 ;;=1^728.86
 ;;^UTILITY(U,$J,358.3,24233,1,2,0)
 ;;=2^NECROTIZING FASCIITIS
 ;;^UTILITY(U,$J,358.3,24233,2)
 ;;=^303314
 ;;^UTILITY(U,$J,358.3,24234,0)
 ;;=730.20^^133^1476^12
 ;;^UTILITY(U,$J,358.3,24234,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24234,1,1,0)
 ;;=1^730.20
 ;;
 ;;$END ROU IBDEI1DA
